New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 19, 2014
16:07 EDTFCSCFibrocell Science reports Q1 EPS (35c), consensus (15c)
Reports Q1 revenue $46K, consensus $80K. The company used $6.0M in cash for operations during Q1 and, as of March 31, total cash and cash equivalents were $54.0M.
News For FCSC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 18, 2015
16:13 EDTFCSCFibrocell Science appoints Keith Goldan as CFO
Fibrocell Science announced the appointment of Keith Goldan as senior VP and Chief Financial Officer, effective immediately. Prior to joining Fibrocell, Goldan served as CFO of two publicly traded companies. Most recently he served as SVP and CFO of NuPathe, which was acquired by Teva Pharmaceutical (TEVA) in 2014.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use